Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilostazol and isosorbide mononitrate for cerebral small vessel disease after lacunar stroke
ISRCTN12580546Phase 2Completed
- Sponsor
- University of Edinburgh
- Start
- Nov 2015
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial of cilostazol and isosorbide mononitrate in Cerebral Small Vessel Disease (CSVD) and ischemic stroke (4 arms), sponsored by University of Edinburgh. Primary endpoint: Achievement of target dose. Started Nov 2015; status: completed.
02
Drugs
cilostazolisosorbide mononitrate
03
Conditions
Cerebral Small Vessel Disease (CSVD)ischemic stroke
Beyond the preview
Go deeper on ISRCTN12580546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN12580546.